Company: BKYI
Filing Date: 2025-04-25
Form Type: S-1
Source: 0001437749-25-013165
Chunk: 14

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-04-25
Form: S-1
Chunk 14
---
div>

The selling stockholder will receive all proceeds from the sale of the shares of common stock offered hereby. We will not receive any proceeds from the sale of common stock by the selling stockholder.

We will, however, receive cash proceeds equal to the exercise price of the warrants. Accordingly, we may receive aggregate gross proceeds of up to $6,647,086.20 assuming that the Series A Warrants and Series B Warrants are each exercised in full at an exercise price of $2.15 per share. We expect to use any proceeds received by us from the exercise of the warrants for working capital purposes and general corporate purposes, including repayment of a portion of the Company’s outstanding secured note.

We will bear all costs, expenses and fees in connection with the registration of the shares, including, without limitation, all registration and filing fees and fees and expenses of our counsel and our accountants.

<div align='center'>DETERMINATION OF OFFERING PRICE</div>

The selling stockholder will offer common stock at the prevailing market prices or privately negotiated prices. The offering price of our common stock does not necessarily bear any relationship to our book value, assets, past operating results, financial condition or any other established criteria of value. Our common stock may not trade at the market prices in excess of the offering prices for common stock in any public market will be determined in the marketplace and may be influenced by many factors, including the depth and liquidity.

<div align='center'>7

SELLING STOCKHOLDER</div>

When we refer to the“selling stockholder”in this prospectus, we mean the persons or entities specifically identified in the table below, as well as the permitted transferees, pledges, donees, assignees, successors and other successors-in-interest who may subsequently hold any of the selling stockholder’s interests other than through a public sale.

The selling stockholder identified in the following table is offering for resale 3,091,668 shares of our common stock. All of the securities were previously issued to the selling stockholder in private placement transactions described above under the section entitled “The Offering”.

The following table sets forth:

| ● | The name of the selling stockholder and any material relationship between us and the selling stockholder based upon information currently available to us; |
| ● | The number of shares owned beneficially by the selling stockholder before the offering;                                                                    |
| ● | The percentage ownership of the selling stockholder prior to the offering;                                                                                 |
| ● | The number of shares offered here